The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Tag Archives: NIH Funding

Monday Biotech Deal Review: August 9, 2010

Catching up from the long weekend last week, we have a full two weeks’ worth of deals to bring you. Highlights include $16.7 million of securities closings, $8.25 million launched; and interesting developments in the Forbes Medi-Tech and Northstar Healthcare acquisitions. Check out what the last two weeks have wrought…

Brain Dump: Vacation Edition

A bit of catching up from the last few days: Sanofi makes a further move into generics, continuing the trend we’ve noted of big pharma moving in a big way into international small molecule generics and domestic biosimilars. A new tool from the NIH — RePORT, which replaces the CRISP system – is a powerful way to search for [...]

Allocating Spending to Support R&D: UK, U.S. and Canadian Approaches

The U.S., Canada and the UK have all acknowledged the central importance of R&D even in these recessionary times.  However, the three national governments have decided to focus their spending on different steps of the R&D equation: Education: UK Takes the Long View British PM Gordon Brown, in a speech this week, identified three priorities: research, education and training, [...]

Bright Spot for Canada in NIH Gains?

You may not know this, but Canadian researchers can compete for NIH extramural funds, and they do so quite successfully.  I reviewed the 2008 data from the NIH budget site, which shows that Canadian researchers were awarded $47.4 million in 2008 (out of a total of $212.4 million total awarded outside the U.S.).  Hopefully this [...]

Follow

Get every new post delivered to your Inbox.

Join 93 other followers